Skip to main content
SpringerLink
Log in
Book cover

Multidetector-Row Computed Tomography pp 121–131Cite as

Late Adverse Events Following Administration of Iodinated Contrast Media: An Update

  • Chapter

  • 1639 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morcos SK, Thomsen HS, Webb JAW and members of the contrast media safety committee of the European Society of Urogenital Radiology (ESUR) (1999) Contrast media induced nephrotoxicity: A consensus report. Eur Radiol 9:1602–1613

    Article  PubMed  CAS  Google Scholar 

  2. Thomsen HS, Morcos SK (2003) Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. Br J Radiol 76:513–518

    PubMed  CAS  Google Scholar 

  3. McCullough PA, Sandberg KA (2003) Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 4[Suppl 5]:S3–S9

    Google Scholar 

  4. Thomsen HS (2003) Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 181:1463–1471

    PubMed  Google Scholar 

  5. Lasser EC, Lyon SG, Barry CC (1997) Report on contrast media reactions: analysis of data from reports to the US Food and Drug Administration. Radiology 203:605–610

    PubMed  CAS  Google Scholar 

  6. McCullough PA, Wolyn R, Racher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 103:368–375

    Article  PubMed  CAS  Google Scholar 

  7. Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264

    Article  PubMed  Google Scholar 

  8. Murphy SW, Barrett BJ, Parfrey PS (2000) Contrast nephropathy. J Am Soc Nephrol 11:177–182

    PubMed  CAS  Google Scholar 

  9. Gutierrez N, Diaz A, Timmis GC et al (2002) Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol 15:349–354

    Google Scholar 

  10. Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489–1494

    PubMed  CAS  Google Scholar 

  11. Gruberg I, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration within 48 hours of intervention in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548

    Article  PubMed  CAS  Google Scholar 

  12. Best PJ, Lennon R, Ting HH et al (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113–1119

    Article  PubMed  Google Scholar 

  13. Rudnick MR, Goldfarb S, Wexler L et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 47:254–261

    PubMed  CAS  Google Scholar 

  14. Durham JD, Caputo C, Dokko J et al (2002) A randomized controlled trial of N-acetyslcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62:2202–2207

    Article  PubMed  CAS  Google Scholar 

  15. Hans S, Hans BA, Dhillon R et al (1998) Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency. Am Surg 64:432–436

    PubMed  CAS  Google Scholar 

  16. Aspelin P, Aubry P, Fransson SG et al (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499

    Article  PubMed  CAS  Google Scholar 

  17. Baker CSR, Wragg A, Kumar S et al (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41:2114–2118

    PubMed  Google Scholar 

  18. Boccalandro F, Amhad M, Smalling RW, Sdringola S (2003) Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Cathet Cardiovasc Interv 58:336–341

    Article  Google Scholar 

  19. Stone G, McCullough PA, Tumlin JA et al (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy. A randomized controlled trial. JAMA 290:2284–2291

    Article  PubMed  CAS  Google Scholar 

  20. Taliercio CP, Vlietstra RE, Ilstrup DM et al (1991) A randomized comparison of nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol 17:384–390

    Article  PubMed  CAS  Google Scholar 

  21. Kay J, Chow WH, Chan TM et al (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. JAMA 289:553–558

    PubMed  CAS  Google Scholar 

  22. Oldemeyer JB, Biddle WP, Wurdeman RL et al (2003) Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. Am Heart J 146:e23

    Article  PubMed  CAS  Google Scholar 

  23. Goldenberg I, Shechter M, Matezky S et al (2004) Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. Eur Heart J 25:212–217

    Article  PubMed  CAS  Google Scholar 

  24. Huber W, Ilgmann K, Page M et al (2002) Effect of theophylline on contrast material-induced nephropathy in patients with chronic renal insufficiency: Controlled, randomized, double-blinded study. Radiology 223:772–779

    PubMed  CAS  Google Scholar 

  25. Briguori C, Manganelli F, Scarpato P et al (2002) Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 40:298–303

    PubMed  CAS  Google Scholar 

  26. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW (2002) Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89:356–358

    Article  PubMed  CAS  Google Scholar 

  27. Carraro M, Matalan F, Antonione P et al (1998) Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur Radiol 8:144–147

    Article  PubMed  CAS  Google Scholar 

  28. Kolehmainen H, Soiva M (2003) Comparison of Xenetix 300 and Visipaque 320 in patients with renal failure. Eur Radiol 13:B32–B33

    Google Scholar 

  29. Haight AE, Kaste SC, Goloubeva OG et al (2003) Nephrotoxocity of iopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation. Radiology 226:399–404

    PubMed  Google Scholar 

  30. Lee JK, Warshauer DM, Bush WH Jr et al (1995) Determination of serum creatinine level before intravenous administration of iodinated contrast medium. A survey. Invest Radiol 30:700–705

    PubMed  CAS  Google Scholar 

  31. Trivedi HS, Moore H, Nasr S et al (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephropathy. Nephron Clin Pract 93:C29–C34

    Article  PubMed  CAS  Google Scholar 

  32. Mueller C, Buerkle G, Buettner HJ et al (2002) Prevention of contrast media-associated nephropathy. Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329–336

    PubMed  CAS  Google Scholar 

  33. Merten GJ, Burgess WP, Gray LV et al (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA 291:2328–2334

    Article  PubMed  CAS  Google Scholar 

  34. Yasuda R, Munechika H (1998) Delayed adverse reactions to nonionic monomeric contrast-enhanced media. Invest Radiol 33:1–5

    Article  PubMed  CAS  Google Scholar 

  35. Christiansen C, Pichler WJ, Skotland T (2000) Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 10:1965–1975

    Article  PubMed  CAS  Google Scholar 

  36. Yoshikawa H (1992) Late adverse reactions to nonionic contrast media. Radiology 183:737–740

    PubMed  CAS  Google Scholar 

  37. Webb JAW, Stacul F, Thomsen HS et al (2003) Members Of The Contrast Media Safety Committee Of The European Society Of Urogenital Radiology, Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 13:181–184

    PubMed  Google Scholar 

  38. Munechika H (1996) Delayed reaction of monomeric contrast media: comparison of plain and enhanced computed tomography. Eur Radiol 6:S16

    Article  Google Scholar 

  39. Sutton AGC, Finn P, Grech ED et al (2001) Early and late reactions after the use of iopamidol 340, ioxaglate 32 and iodixanol 320 in cardiac catheterization. Am Heart J 141:677–683

    Article  PubMed  CAS  Google Scholar 

  40. Sanchez-Perez J, F-Villalta MG, Ruiz SA et al (2003) Delayed hypersensitivity reaction to the non-ionic X-ray contrast medium Visipaque (iodixanol). Contact Dermatitis 48:167

    PubMed  Google Scholar 

  41. Vernassiere C, Trechot P, Commun N et al (2004) Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis 50:359–366

    Article  PubMed  CAS  Google Scholar 

  42. Speck U, Bohle F, Krause W et al (1998) Delayed hypersensitivity to X-ray CM: possible mechanisms and models. Acad Radiol 5[Suppl 1]:S162–S165

    PubMed  Google Scholar 

  43. Sutton AGC, Finn P, Campbell PG et al (2003) Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. J Invas Cardiol 15:133–138

    CAS  Google Scholar 

  44. Ueda S, Mori H, Matsumoto S et al (2001) True delayed adverse reactions to non-ionic contrast media: a cohort analytic study. Eur Radiol 11[Suppl 1]:377

    Google Scholar 

  45. Hoyosa T, Yamaguchi K, Akutsu T et al (2000) Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med 18:39–45

    Google Scholar 

  46. Mikkonen R, Vehmas T, Granlund H et al (2000) Seasonal variation in the occurrence of late adverse skin reactions to iodine-based contrast media. Acta Radiol 41:390

    Article  PubMed  CAS  Google Scholar 

  47. Choyke PL, Miller DL, Lotze MT et al (1992) Delayed skin reactions to contrast media after interleukin2 immunotherapy. Radiology 183:111–114

    PubMed  CAS  Google Scholar 

  48. Oldham RK, Brogley J, Braud E (1990) Contrast medium “recalls” interleukin-2 toxicity. J Clin Oncol 8:942–943

    PubMed  CAS  Google Scholar 

  49. Shulman KL, Thompson JA, Benyunes MC et al (1993) Adverse reaction to intravenous contrast media in patients treated with interleukin-2. J Immunother 13:208–212

    PubMed  CAS  Google Scholar 

  50. Zukiwski AA, David CL Coan J et al (1990) Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration. Cancer 65:1521–1524

    PubMed  CAS  Google Scholar 

  51. Panto PN, Davies P (1986) Delayed reactions to urographic contrast media. Br J Radiol 59:41–44

    PubMed  CAS  Google Scholar 

  52. Pedersen SH, Svaland MG, Reiss AL et al (1998) Late allergy-like reactions following vascular administration of radiography contrast media. Acta Radiol 39:344–348

    Article  PubMed  CAS  Google Scholar 

  53. McCullough M, Davies P, Richardson R (1989) A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions. Br J Radiol 62:260–265

    PubMed  CAS  Google Scholar 

  54. Srodon P, Matson M, Ham R (2003) Contrast nephropathy in lower limb angiography. Ann R Coll Surg Engl 85:177–191

    Article  Google Scholar 

Download references

Authors
  1. Alberto Spinazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, University Hospitals Leuven, Leuven, Belgium

    Guy Marchal

  2. Department of Radiology, University of Frankfurt, Frankfurt am Main, Germany

    Thomas J. Vogl

  3. Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, USA

    Jay P. Heiken

  4. Department of Radiology, Stanford University School of Medicine, Stanford, USA

    Geoffrey D. Rubin

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Italia

About this chapter

Cite this chapter

Spinazzi, A. (2005). Late Adverse Events Following Administration of Iodinated Contrast Media: An Update. In: Marchal, G., Vogl, T.J., Heiken, J.P., Rubin, G.D. (eds) Multidetector-Row Computed Tomography. Springer, Milano. https://doi.org/10.1007/88-470-0363-6_18

Download citation

  • DOI: https://doi.org/10.1007/88-470-0363-6_18

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0305-7

  • Online ISBN: 978-88-470-0363-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation